SHMT-IN-3 (Hit 1) is a potent, non-competitive serine hydroxymethyltransferase (SHMT) inhibitor, demonstrating an IC50 of 0.53 µM against human SHMT1. This compound is a valuable chemical probe for investigating one-carbon metabolism in cancer research, applicable in both cellular and biochemical in vitro studies.